-
Mashup Score: 1Home - BCMA Targeted Therapies - 3 year(s) ago
PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more
Source: BCMA Targeted TherapiesCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Home - BCMA Targeted Therapies - 3 year(s) ago
PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more
Source: BCMA Targeted TherapiesCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Home - BCMA Targeted Therapies - 3 year(s) ago
PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more
Source: BCMA Targeted TherapiesCategories: Hem/Oncs, Latest HeadlinesTweet
Concluding today: Virtual Summit on BCMA Targeted Therapies. June 21-23, 2021 Exclusive Online Event 9.20-3.40 EST | 6.20 - 12.40 PST. #Myeloma will of course feature prominently in this event! https://t.co/Sg1rpwysh3 https://t.co/iOabVxZg9z